Back
Terns Pharmaceuticals, Inc. Stock Predictions
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
52
TERN
Terns Pharmaceuticals, Inc.
Last Price:
$39.33
Seasonality Move:
-22.3%
7 Day Trial
ALL ACCESS PASS
$
7
Terns Pharmaceuticals, Inc. Stock Forecast
-
Over the next 52 weeks, Terns Pharmaceuticals, Inc. has on average historically risen by 207.4% based on the past 5 years of stock performance.
-
Terns Pharmaceuticals, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
-
Is Terns Pharmaceuticals, Inc. Stock Undervalued?The current Terns Pharmaceuticals, Inc. [TERN] share price is $42.03. The Score for TERN is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
TERN is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
Will Terns Pharmaceuticals, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Terns Pharmaceuticals, Inc. has on average historically risen by 207.4% based on the past 5 years of stock performance.
Terns Pharmaceuticals, Inc. Stock Rating
Buy
52
Terns Pharmaceuticals, Inc. (TERN)
is a Buy
Is Terns Pharmaceuticals, Inc. overpriced?
-
Terns Pharmaceuticals, Inc. has risen higher in 2 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 40%
Terns Pharmaceuticals, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
ternspharma.com
52-Week Data
52-Week High:
48.26
52-Week Low:
1.87
Prediction Charts
Market Cap:
3.8B
Price in USD:
42.03
Volume:
1.8M
Beta:
-0.31
Technical Analysis
SMA50:
38.36
SMA100:
29.54
SMA200:
17.54
52-Wk Change:
1039.02%
Stock Predictions
-
Is Terns Pharmaceuticals, Inc. stock public?Yes, Terns Pharmaceuticals, Inc. is a publicly traded company.
-
What is the Terns Pharmaceuticals, Inc. stock quote today?The Terns Pharmaceuticals, Inc. stock price is 42.03 USD today.
-
How to buy Terns Pharmaceuticals, Inc. stock online?You can buy Terns Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Feb-10 | 37.75 | 38.19 | 38.63 | 37.30 |
| Feb-11 | 38.67 | 38.64 | 39.60 | 37.02 |
| Feb-12 | 39.14 | 37.75 | 39.54 | 37.63 |
| Feb-13 | 37.78 | 37.79 | 38.80 | 37.04 |
| Feb-17 | 37.91 | 39.58 | 40.47 | 37.40 |
| Feb-18 | 39.94 | 39.35 | 40.87 | 39.01 |
| Feb-19 | 39.19 | 39.45 | 39.93 | 37.81 |
| Feb-20 | 39.28 | 39.23 | 39.99 | 38.77 |
| Feb-23 | 39.13 | 40.86 | 41.52 | 38.77 |
| Feb-24 | 40.88 | 41.45 | 41.52 | 39.83 |
| Feb-25 | 41.15 | 41.38 | 42.13 | 40.84 |
| Feb-26 | 41.44 | 40.92 | 41.58 | 39.38 |
| Feb-27 | 40.40 | 42.12 | 42.24 | 39.93 |
| Mar-2 | 41.00 | 42.03 | 42.88 | 40.52 |
Terns Pharmaceuticals, Inc. Earnings
Terns Pharmaceuticals, Inc. Earnings Report: Per Share Terns Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Terns Pharmaceuticals, Inc. Forecast Revenue Growth
Terns Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Terns Pharmaceuticals, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.16 per share, and a decrease next year of $0.30 per share.
* Terns Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.